If such a trial is in fact being planned, it must be either: a) a trial for the ex-US market; or b) a bioequivalence trial (as opposed to a safety and efficacy trial).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.